Index | RUT |
Market Cap | 583.10M |
Enterprise Value | 725.00M |
Income | 6.71M |
Sales | 249.13M |
Book/sh | 33.71 |
Cash/sh | 4.87 |
| |
| |
| |
| |
| |
Employees | 717 |
IPO | Feb 29, 1984 |
P/E | 87.40 |
Forward P/E | 8.54 |
PEG | - |
P/S | 2.34 |
P/B | 3.13 |
P/C | 21.65 |
P/FCF | 14.73 |
EV/EBITDA | 17.35 |
EV/Sales | 2.91 |
Quick Ratio | 1.29 |
Current Ratio | 1.72 |
Debt/Eq | 0.91 |
LT Debt/Eq | 0.86 |
Option/Short | No / Yes |
EPS (ttm) | 1.21 |
EPS next Y | 12.36 |
EPS next Q | 2.62 |
EPS this Y | 3.24% |
EPS next Y | 4.92% |
EPS next 5Y | - |
EPS past 3/5Y | 90.85% 13.55% |
Sales past 3/5Y | 4.38% 13.22% |
EPS Y/Y TTM | 445.05% |
Sales Y/Y TTM | 3.38% |
EPS Q/Q | 42.97% |
Sales Q/Q | 2.56% |
| |
| |
Insider Own | 3.42% |
Insider Trans | -1.13% |
Inst Own | 87.71% |
Inst Trans | 1.25% |
ROA | 1.56% |
ROE | 3.88% |
ROIC | 1.94% |
Gross Margin | 56.56% |
Oper. Margin | 7.43% |
Profit Margin | 2.69% |
SMA20 | 3.80% |
SMA50 | 3.56% |
SMA200 | 21.89% |
Trades | |
Shs Outstand | 5.52M |
Shs Float | 5.34M |
| |
| |
| |
52W High | 113.99 -7.41% |
52W Low | 55.45 90.33% |
Volatility | 5.15% 5.51% |
ATR (14) | 5.71 |
RSI (14) | 56.31 |
Beta | 0.91 |
Rel Volume | 0.68 |
Avg Volume | 173.56K |
Volume | 117,356 |
Perf Week | 7.53% |
Perf Month | -1.05% |
Perf Quarter | 19.31% |
Perf Half Y | 34.27% |
Perf YTD | 34.45% |
Perf Year | 4.88% |
Perf 3Y | -17.87% |
Perf 5Y | -61.15% |
Perf 10Y | -15.56% |
| |
| |
Prev Close | 104.39 |
Price | 105.54 |
Change | 1.10% |
|
 |
|
|
 |
|  |
| Date |
Action |
Analyst |
Rating Change |
Price Target Change |
| Aug-07-25 | Upgrade |
Wells Fargo |
Underweight → Equal Weight |
$67 |
| Aug-28-24 | Initiated |
Wells Fargo |
Underweight |
$120 |
| Jan-04-24 | Upgrade |
Evercore ISI |
In-line → Outperform |
$100 → $125 |
| Jan-04-21 | Downgrade |
Evercore ISI |
Outperform → In-line |
$300 |
| Nov-10-20 | Initiated |
KeyBanc Capital Markets |
Sector Weight |
$287 |
| Oct-02-20 | Initiated |
JP Morgan |
Neutral |
$260 |
| Dec-04-19 | Initiated |
Jefferies |
Buy |
|
| Aug-26-19 | Initiated |
Evercore ISI |
Outperform |
$250 |
| Jun-10-16 | Downgrade |
Sidoti |
Buy → Neutral |
|
|
 |
|
Jun-17-26 04:42AM
|
|
|
May-27-26 08:18AM
|
(Associated Press)
-14.48%
|
|
08:00AM
|
|
|
May-05-26 01:39PM
|
|
|
Apr-02-26 06:00PM
|
|
| 04:30PM |
Loading… |
|
Mar-09-26 04:30PM
|
|
|
Feb-20-26 07:02AM
|
|
|
Feb-03-26 08:11AM
|
(Associated Press Finance)
+8.73%
|
|
08:00AM
|
|
|
Jan-07-26 05:00PM
|
|
|
Dec-18-25 07:00PM
|
|
|
Dec-03-25 05:35PM
|
|
|
Nov-25-25 08:09AM
|
|
|
Nov-12-25 03:14PM
|
|
|
Nov-06-25 07:01PM
|
(Associated Press Finance)
|
| 04:15PM |
Loading… |
|
04:15PM
|
|
|
Oct-03-25 11:46AM
|
|
|
11:01AM
|
|
|
Sep-22-25 06:53AM
|
|
|
Sep-05-25 06:34PM
|
|
|
Aug-18-25 02:01PM
|
|
|
Aug-05-25 09:15AM
|
|
|
08:10AM
|
(Associated Press Finance)
|
|
08:00AM
|
|
|
Jul-31-25 05:45PM
|
|
|
Jul-03-25 12:00PM
|
|
|
Jul-02-25 03:20PM
|
|
|
May-28-25 09:15AM
|
|
|
08:23AM
|
(Associated Press Finance)
|
|
08:00AM
|
|
| 05:25PM |
Loading… |
|
May-15-25 05:25PM
|
|
|
May-14-25 05:45PM
|
|
|
May-13-25 05:35PM
|
|
|
May-08-25 08:45AM
|
|
|
Apr-07-25 03:00PM
|
|
|
Apr-03-25 03:51PM
|
|
|
Mar-26-25 12:00PM
|
|
|
Feb-13-25 08:31AM
|
|
|
Feb-11-25 12:20PM
|
|
|
Feb-04-25 09:15AM
|
|
|
08:17AM
|
(Associated Press Finance)
|
|
08:00AM
|
|
|
Jan-17-25 01:15PM
|
|
|
Jan-06-25 03:00PM
|
|
|
Nov-07-24 09:20AM
|
|
|
08:27AM
|
(Associated Press Finance)
|
|
08:00AM
|
|
|
Oct-15-24 05:02PM
|
|
|
Oct-02-24 02:00PM
|
|
|
Aug-26-24 12:20PM
|
|
|
12:00PM
|
|
|
Aug-16-24 07:51AM
|
|
|
Aug-05-24 08:15AM
|
(Associated Press Finance)
|
|
08:00AM
|
|
|
Jul-31-24 09:14AM
|
|
|
Jul-08-24 02:00PM
|
|
|
Jun-05-24 11:53AM
|
|
|
06:38AM
|
|
|
06:21AM
|
(Associated Press Finance)
|
|
06:00AM
|
|
|
May-31-24 06:00AM
|
|
|
May-22-24 06:00AM
|
|
|
Apr-08-24 08:00AM
|
|
|
Apr-04-24 06:24PM
|
|
|
Apr-01-24 10:27AM
|
|
|
Mar-15-24 07:00AM
|
|
|
Feb-19-24 10:23AM
|
|
|
Feb-05-24 09:20AM
|
|
|
08:36AM
|
|
|
08:22AM
|
(Associated Press Finance)
|
|
08:00AM
|
|
|
Jan-08-24 08:00AM
|
|
|
Jan-04-24 03:00PM
|
|
|
Jan-03-24 08:00AM
|
|
|
Dec-14-23 10:47AM
|
|
|
Nov-06-23 09:10AM
|
|
|
08:13AM
|
(Associated Press Finance)
|
|
08:00AM
|
|
|
Oct-16-23 03:00AM
|
|
|
Oct-03-23 08:00AM
|
|
|
Sep-22-23 08:09AM
|
|
|
06:20AM
|
|
|
Sep-15-23 01:10AM
|
|
|
Sep-13-23 01:37PM
|
|
|
Sep-11-23 11:21AM
|
|
|
Aug-24-23 04:02PM
|
|
|
Aug-10-23 01:32AM
|
|
|
Aug-03-23 09:35AM
|
|
|
08:27AM
|
|
|
08:00AM
|
|
|
Jul-31-23 07:50AM
|
|
|
Jul-05-23 03:00PM
|
|
|
Jun-21-23 08:00PM
|
|
|
11:50AM
|
|
|
May-25-23 09:25AM
|
|
|
08:14AM
|
|
|
08:00AM
|
|
|
May-22-23 01:16PM
|
|
|
May-02-23 06:23AM
|
|
|
Apr-26-23 08:00PM
|
|
|
|
|
 |
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Clinical Genomics segment division develops, manufactures and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables and services that enable clinical research labs and contract research organizations. The Biopharmaceutical Development segment caters and sells automated systems for protein analysis and peptide synthesis solutions. The Calibration Solutions segment focuses on the quality control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications such as renal care, environmental and process monitoring, gas flow, air quality and torque testing, primarily in medical device manufacturing, pharmaceutical manufacturing, laboratory and hospital environments. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO. |  |
|
 | VP & CFOMr. John V. Sakys C.P.A. Senior Vice President of Continuous ImprovementMr. Brian David Archbold M.S.Dr. Siddhartha Chandrakant Kadia B.E. Chief Accounting OfficerMs. Lyndsey Crennen |
|
 |
|  |
|
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Crennen Lyndsey Elizabeth | CAO | Jun 18 '26 | Option Exercise | 95.10 | 726 | 69,043 | 2,199 | Jun 23 01:34 PM | | Crennen Lyndsey Elizabeth | CAO | Jun 22 '26 | Sale | 89.50 | 442 | 39,560 | 2,020 | Jun 23 01:34 PM | | Archbold Brian David | SVP Operations | Jun 18 '26 | Option Exercise | 95.10 | 3,324 | 316,112 | 7,034 | Jun 23 01:02 PM | | Archbold Brian David | SVP Operations | Jun 22 '26 | Sale | 89.50 | 2,516 | 225,187 | 6,377 | Jun 23 01:02 PM | | Sakys John | CFO | Jun 18 '26 | Option Exercise | 95.10 | 3,792 | 360,619 | 20,330 | Jun 23 12:23 PM | | Sakys John | CFO | Jun 22 '26 | Sale | 89.50 | 2,827 | 253,022 | 19,785 | Jun 23 12:23 PM | | Sakys John | Officer | Jun 22 '26 | Proposed Sale | 89.50 | 2,827 | 253,022 | | Jun 22 03:56 PM | | Archbold Brian David | Officer | Jun 22 '26 | Proposed Sale | 89.50 | 2,516 | 225,187 | | Jun 22 03:51 PM | | Archbold Brian David | SVP Operations | Jun 16 '26 | Sale | 101.27 | 1,151 | 116,558 | 3,710 | Jun 17 12:23 PM | | Crennen Lyndsey Elizabeth | CAO | Jun 16 '26 | Sale | 101.27 | 118 | 11,950 | 1,473 | Jun 17 12:19 PM | | Sakys John | CFO | Jun 16 '26 | Sale | 101.27 | 1,223 | 123,850 | 16,538 | Jun 17 12:09 PM | | Archbold Brian David | Officer | Jun 16 '26 | Proposed Sale | 101.27 | 1,151 | 116,558 | | Jun 16 03:33 PM | | Sakys John | Officer | Jun 16 '26 | Proposed Sale | 101.27 | 1,223 | 123,850 | | Jun 16 03:31 PM | | Owens Gary M | Former Officer | Jun 16 '26 | Proposed Sale | 101.27 | 3,706 | 375,296 | | Jun 16 03:29 PM | | Archbold Brian David | SVP Operations | Jun 15 '26 | Option Exercise | 104.08 | 2,454 | 255,412 | 4,861 | Jun 16 02:44 PM | | Sakys John | CFO | Jun 15 '26 | Option Exercise | 104.08 | 2,717 | 282,785 | 17,761 | Jun 16 02:15 PM | | Ladiwala Shiraz Shabanali | Director | Mar 10 '26 | Buy | 72.23 | 3,500 | 252,805 | 8,523 | Mar 10 05:43 PM | | Capone Mark Christopher | Director | Mar 10 '26 | Buy | 76.35 | 1,301 | 99,331 | 3,429 | Mar 10 03:46 PM | | Tripeny R Tony | Director | Mar 10 '26 | Buy | 76.00 | 1,315 | 99,940 | 5,398 | Mar 10 03:39 PM | | Owens Gary M | President and CEO | Oct 27 '25 | Option Exercise | 0.00 | 11,558 | 0 | 64,135 | Oct 28 03:08 PM | | Ladiwala Shiraz Shabanali | Director | Aug 15 '25 | Option Exercise | 0.00 | 1,949 | 0 | 5,023 | Aug 18 02:37 PM | | Sullivan John James | Director | Aug 15 '25 | Option Exercise | 0.00 | 1,404 | 0 | 27,282 | Aug 18 02:20 PM | | Hall Shannon | Director | Aug 15 '25 | Option Exercise | 0.00 | 1,404 | 0 | 4,189 | Aug 18 02:02 PM | | Tripeny R Tony | Director | Aug 15 '25 | Option Exercise | 0.00 | 1,404 | 0 | 4,083 | Aug 18 01:54 PM | | Capone Mark Christopher | Director | Aug 15 '25 | Option Exercise | 0.00 | 1,404 | 0 | 2,128 | Aug 18 01:45 PM | | Alltoft Jennifer Sadie | Director | Aug 15 '25 | Option Exercise | 0.00 | 1,404 | 0 | 4,878 | Aug 18 01:34 PM |
|
|